Nederman (NMAN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Jul, 2026Executive summary
Maintained resilience and strong activity across all divisions despite a volatile market, though order intake and sales declined year-over-year.
Strengthened position in structurally growing industries such as food, pharma, life sciences, wind power, hydrogen, batteries, and recycling, but this led to lower sales and EBIT margins.
Activity picked up at the end of Q1 and continued into April, with broad-based improvement except for slower APAC.
Continued investments in automation, operational efficiency, and digitalization across divisions.
Cash flow from operations was negative, mainly due to working capital build-up, which is typical for Q1.
Financial highlights
Orders received were SEK 1,267m, down from just over SEK 1,500m in Q1 last year; 6.7% down currency neutral, 9.2% organic decline.
Sales were SEK 1,257m, down 2% currency neutral and 5.5% organically; currency impact was -9% on both orders and sales.
Adjusted EBITA/EBITDA was SEK 117m (Q1 2025: SEK 143m); margin 9.3% (Q1 2025: 10.1%).
Earnings per share SEK 1.31 (Q1 2025: SEK 1.69).
Net debt was SEK 1,964m as of March 31, 2026 (1,886m SEK prior year); equity ratio improved to 38.0%.
Outlook and guidance
Demand remains subdued in many sectors, but strong service and digital offerings support performance.
Activity picked up late in Q1; if sustained, could improve future quarters.
Considerable market uncertainty persists, making broader demand recovery difficult to forecast.
Well-positioned to improve profitability when demand recovers, supported by a strong balance sheet and ongoing investments.
Latest events from Nederman
- Order intake up 6.3% YoY, sales and margins down, but cash flow and backlog support a positive outlook.NMAN
Q2 2026 - Market leader in industrial air filtration, driving growth through innovation and service.NMAN
Aktiedagarna 2026 - Currency-neutral growth and strong cash flow, but margins pressured by external factors.NMAN
Q4 2025 - Sales and profitability improved in Q3 2025, but orders declined amid market uncertainty.NMAN
Q3 2025 - Currency-neutral growth led by Extraction & Filtration, but margins and profit declined.NMAN
Q2 2025 - Strong order intake, solid margins, and investments drive resilience amid market headwinds.NMAN
Q3 2024 - Strong margins and stable cash flow achieved despite lower sales and orders; outlook positive.NMAN
Q2 2024 - Strong orders in most divisions, but profit fell due to currency and acquisition costs.NMAN
Q1 2025 - Record net profit, strong cash flow, and strategic growth amid macroeconomic uncertainty.NMAN
Q4 2024